Heparin cofactor 2 (SERPIND1)

Thrombin inhibitor activated from the glycosaminoglycans, heparin or dermatan sulfate. In the presence of the latter, HC-II becomes the predominant thrombin inhibitor in place of antithrombin III (AT-III).

Also inhibits chymotrypsin, but in a glycosaminoglycan-independent method. .